A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
Clinical trial NCT04951076 · COMPLETED
Trial details
- NCT number
- NCT04951076
- Sponsor
- Bionomics Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2023-07-25
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.